Personalized brain cancer vaccine after standard treatment
Part of Brain & nervous system, Cancer clinical trials.
This trial tests a personalized vaccine made from your own tumor cells, given after standard treatment (surgery and chemo/radiation) for newly diagnosed glioblastoma. The vaccine aims to train your immune system to fight any remaining cancer cells.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with glioblastoma (a fast-growing brain tumor)
- You plan to have surgery to remove the tumor
- You will need to give a sample of your blood and tumor tissue for this study
- You are able to care for yourself (with or without some help)
- You do not have an autoimmune disease or a serious heart condition
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests adding a vaccine (UCPVax) with or without the immunotherapy drug pembrolizumab to standard chemotherapy after initial treatment. The goal is to see if these extra treatments can help prevent the brain tumor from coming back.
This trial tests a personalized vaccine created by AI to target your specific brain tumor. It is for people with a glioma that came back after standard treatments like surgery, radiation, or chemotherapy, and whose tumor has enough genetic mutations to make the vaccine.
This trial offers a personalized vaccine (DCVax-L) made from your own tumor cells to patients with glioblastoma (a type of brain cancer) who were not able to join a previous study. The vaccine aims to help your immune system fight the cancer.
This trial tests a vaccine made from your own immune cells to fight glioblastoma, a type of brain cancer. It may help your body attack the cancer more effectively after standard treatments.
This trial tests a personalized cancer vaccine made from your own tumor, combined with standard chemotherapy and a drug that helps your immune system fight the cancer. It aims to see if this combination can improve outcomes for people with glioblastoma.
This trial tests a personalized vaccine made from your own immune cells (a dendritic cell vaccine) that may help your body fight the brain tumor. It is meant for people with DIPG or glioblastoma who have already tried standard treatments but still have tumors.
Hear when a new Primary Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.